Content deleted Content added
m WP:CHECKWIKI error fix for #03. No {{Reflist}}, Do general fixes if a problem exists. - using AWB (10480) |
Materialscientist (talk | contribs) fmt |
||
Line 1: | Line 1: | ||
{{Unreferenced|date=December 2009}} |
|||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = 461769300 |
| verifiedrevid = 461769300 |
||
Line 50: | Line 49: | ||
==Synthesis== |
==Synthesis== |
||
[[File:Hexylcaine synthesis.png|thumb|center|700px|Hexylcaine synthesis |
[[File:Hexylcaine synthesis.png|thumb|center|700px|Hexylcaine synthesis<ref>{{cite journal|last1=Cope|first1=Arthur C.|last2=Hancock|first2=Evelyn M.|title=1-Alkylamino-2-propanols and their p-Nitro- and p-Aminobenzoates|journal=Journal of the American Chemical Society|volume=66|issue=9|year=1944|pages=1453–1456|doi=10.1021/ja01237a010}}</ref>]] |
||
==References== |
==References== |
Revision as of 06:30, 7 November 2014
Clinical data | |
---|---|
ATC code |
|
Pharmacokinetic data | |
Elimination half-life | <10 minutes |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H23NO2 |
Molar mass | 261.359 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Hexylcaine hydrochloride, also called cyclaine (Merck) or osmocaine, is a short-acting local anesthetic. It acts by inhibiting sodium channel conduction. Overdose can lead to headache, tinnitus, numbness and tingling around the mouth and tongue, convulsions, inability to breathe, and decreased heart function.
Synthesis
![](https://upload.wikimedia.org/wikipedia/commons/thumb/9/93/Hexylcaine_synthesis.png/700px-Hexylcaine_synthesis.png)
References
- ^ Cope, Arthur C.; Hancock, Evelyn M. (1944). "1-Alkylamino-2-propanols and their p-Nitro- and p-Aminobenzoates". Journal of the American Chemical Society. 66 (9): 1453–1456. doi:10.1021/ja01237a010.